Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 300
Single User License Price INR 20325
Corporate User License Price USD 900
Corporate User License Price INR 60975
Site License Price USD 600
Site License Price INR 40650
Request a Quote

Report Title

Sucampo Pharmaceuticals Inc (SCMP)-Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 300
Site License USD 600
Enterprise Wide License USD 900
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Sucampo Pharmaceuticals Inc (SCMP)-Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 300
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Sucampo Pharmaceuticals Inc (SCMP)-Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Sucampo Pharmaceuticals Inc (SCMP)-Financial and Strategic SWOT Analysis Review



Executive Summary

Sucampo Pharmaceuticals Inc (SCMP)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sucampo Pharmaceuticals Inc (Sucampo) is a biopharmaceutical company which conducts research, discovers, develops and commercializes proprietary drugs to address unmet medical needs. Its drugs are indicated for the treatment of gastrointestinal, ophthalmic, and cancer-based inflammatory disorders. Its marketed products include Amitiza, which is indicated for the treatment of chronic idiopathic constipation in adults, irritable bowel syndrome with constipation, opioid-induced constipation (OIC) in patients with chronic non-cancer pain and chronic constipation. Other prostone-based product candidates under development include lubiprostone and cobiprostone. The company, through its subsidiaries, operates in the UK, the US, Japan, and Switzerland. Sucampo is headquartered in Bethesda, Maryland, the US.

Sucampo Pharmaceuticals Inc Key Recent Developments

Nov 09, 2016: Sucampo Reports Third Quarter 2016 Financial Results

Aug 03, 2016: Sucampo Reports Second Quarter 2016 Financial Results

Jul 29, 2016: Paul Edick Joins Sucampo's Board of Directors

May 04, 2016: Sucampo Reports Strong Results for First Quarter of 2016

Mar 08, 2016: Sucampo Reports Continued Strong Performance for Fourth Quarter and Full Year 2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Sucampo Pharmaceuticals Inc-Key Facts 6

Sucampo Pharmaceuticals Inc-Key Employees 7

Sucampo Pharmaceuticals Inc-Key Employee Biographies 8

Sucampo Pharmaceuticals Inc-Major Products and Services 9

Sucampo Pharmaceuticals Inc-Pharmaceutical Pipeline Products Data 10

Sucampo Pharmaceuticals Inc, Pipeline Products by Therapy Area 10

Sucampo Pharmaceuticals Inc, Pipeline Products by Development Phase 11

Sucampo Pharmaceuticals Inc-History 13

Sucampo Pharmaceuticals Inc-Company Statement 15

Sucampo Pharmaceuticals Inc-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Section 2-Company Analysis 19

Sucampo Pharmaceuticals Inc-Business Description 19

Sucampo Pharmaceuticals Inc-Corporate Strategy 20

Sucampo Pharmaceuticals Inc-SWOT Analysis 21

SWOT Analysis-Overview 21

Sucampo Pharmaceuticals Inc-Strengths 21

Sucampo Pharmaceuticals Inc-Weaknesses 22

Sucampo Pharmaceuticals Inc-Opportunities 23

Sucampo Pharmaceuticals Inc-Threats 24

Sucampo Pharmaceuticals Inc-Key Competitors 25

Section 3-Company Financial Ratios 26

Financial Ratios-Capital Market Ratios 26

Financial Ratios-Annual Ratios 27

Performance Chart 29

Financial Performance 29

Financial Ratios-Interim Ratios 30

Financial Ratios-Ratio Charts 31

Section 4-Company's Lifesciences Financial Deals and Alliances 32

Sucampo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 32

Sucampo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 33

Sucampo Pharmaceuticals Inc, Recent Deals Summary 34

Section 5-Company's Recent Developments 35

Nov 09, 2016: Sucampo Reports Third Quarter 2016 Financial Results 35

Aug 03, 2016: Sucampo Reports Second Quarter 2016 Financial Results 37

Jul 29, 2016: Paul Edick Joins Sucampo's Board of Directors 39

May 04, 2016: Sucampo Reports Strong Results for First Quarter of 2016 40

Mar 08, 2016: Sucampo Reports Continued Strong Performance for Fourth Quarter and Full Year 2015 42

Jan 07, 2016: Sucampo Provides Update to 2015 and Confirms 2016 Financial Guidance Post Closing of R-Tech Ueno Acquisition 45

Dec 15, 2015: Sucampo CEO Peter Greenleaf Appointed Chairman of the Board of Directors 46

Nov 04, 2015: Sucampo Reports Third Quarter 2015 Financial Results and Provides Corporate Update 47

Oct 13, 2015: Timothy P. Walbert Joins Sucampo's Board Of Directors 50

Aug 05, 2015: Sucampo Reports Second Quarter 2015 Financial Results and Corporate Update 51

Section 6-Appendix 53

Methodology 53

Ratio Definitions 53

About GlobalData 57

Contact Us 57

Disclaimer 57

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Sucampo Pharmaceuticals Inc, Pipeline Products by Therapy Area 10

Sucampo Pharmaceuticals Inc, Pipeline Products by Development Phase 11

Sucampo Pharmaceuticals Inc, Performance Chart (2011-2015) 29

Sucampo Pharmaceuticals Inc, Ratio Charts 31

Sucampo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 32

Sucampo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 33

List of Tables

Sucampo Pharmaceuticals Inc, Key Facts 6

Sucampo Pharmaceuticals Inc, Key Employees 7

Sucampo Pharmaceuticals Inc, Key Employee Biographies 8

Sucampo Pharmaceuticals Inc, Major Products and Services 9

Sucampo Pharmaceuticals Inc, Number of Pipeline Products by Therapy Area 10

Sucampo Pharmaceuticals Inc, Number of Pipeline Products by Development Stage 11

Sucampo Pharmaceuticals Inc, Pipeline Products By Therapy Area and Development Phase 12

Sucampo Pharmaceuticals Inc, History 13

Sucampo Pharmaceuticals Inc, Subsidiaries 18

Sucampo Pharmaceuticals Inc, Key Competitors 25

Sucampo Pharmaceuticals Inc, Ratios based on current share price 26

Sucampo Pharmaceuticals Inc, Annual Ratios 27

Sucampo Pharmaceuticals Inc (Cont...1), Annual Ratios 28

Sucampo Pharmaceuticals Inc, Interim Ratios 30

Sucampo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 32

Sucampo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 33

Sucampo Pharmaceuticals Inc, Recent Deals Summary 34

Currency Codes 53

Capital Market Ratios 53

Equity Ratios 54

Profitability Ratios 54

Cost Ratios 55

Liquidity Ratios 55

Leverage Ratios 55

Efficiency Ratios 56

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Sucampo Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand